ExploreWatchlistsPricing
  1. US-listed companies
  2. Sonnet BioTherapeutics Holdings, Inc.
  3. Financials
  4. Cash from operations

Sonnet BioTherapeutics Holdings, Inc. (SONN)

Market cap
$1.26
P/E ratio
SummaryFinancials
Period EndCash from operations (Million USD)YoY (%)
Sep 30, 2025-13+49.02%
Sep 30, 2024-9-59.67%
Sep 30, 2023-21-22.92%
Sep 30, 2022-28+584.22%
Dec 31, 2019-4-803.48%
Dec 31, 20181-179.40%
Dec 31, 2017-1+66.86%
Dec 31, 2016-0-91.91%
Dec 31, 2015-5+434.33%
Dec 31, 2014-1-62.88%
Dec 31, 2013-3+14.88%
Dec 31, 2012-2+125.38%
Dec 31, 2011-1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat